| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |